Structures by: Aakeröy C. B.
Total: 489
CS---AS-9--3 4-I---F4-PhCHO oxime, 4-(Me2N)-pyridine
(C7H2F4INO)(C7H10N2)
IUCrJ (2015) 2, Pt 5 498-510
a=13.9735(9)Å b=17.2451(11)Å c=13.6166(8)Å
α=90.00° β=105.489(2)° γ=90.00°
S---AV-14--5 4-Br-PhCH(=NOH), 4-(1-pyrrolidinyl)-pyridine
(C7H6BrNO)(C9H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=7.8090(11)Å b=9.6156(14)Å c=11.4520(18)Å
α=101.314(5)° β=94.225(5)° γ=113.541(4)°
SD-1--27-6--4 4-(1-pyrrolidinyl)-pyridine, (4-Br-PhCOOH)2
(C9H12N2)(C7H5BrO2)2
IUCrJ (2015) 2, Pt 5 498-510
a=9.3718(6)Å b=9.6497(6)Å c=14.1666(9)Å
α=98.672(3)° β=105.769(2)° γ=110.884(3)°
D-1--27-6--2 4-(Me2N)-pyridine, 4-Br-PhCOOH
(C7H10N2)(C7H5BrO2)
IUCrJ (2015) 2, Pt 5 498-510
a=13.5603(12)Å b=8.1700(8)Å c=12.2863(12)Å
α=90.00° β=92.157(3)° γ=90.00°
SD---A-1--4 4-I---F4-PhCOOH, 4-benzoylpyridine
(C7HF4IO2)(C12H9NO)2
IUCrJ (2015) 2, Pt 5 498-510
a=25.216(2)Å b=6.0746(5)Å c=19.0419(16)Å
α=90.00° β=107.453(3)° γ=90.00°
CS---AE-5--12 4-iodobenzoic acid, 4,4'-bipyridyl
(C7H5IO2)(C10H8N2)
IUCrJ (2015) 2, Pt 5 498-510
a=6.2888(5)Å b=7.4027(6)Å c=8.1348(6)Å
α=84.773(3)° β=82.604(3)° γ=83.781(2)°
SD---A-1--5 4-iodobenzoic acid, 1,2-bis(4-pyridyl)ethane
(C7H5IO2)(C12H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=10.7653(5)Å b=7.3634(4)Å c=11.4066(6)Å
α=90.00° β=109.025(2)° γ=90.00°
SD-1--20-12--7 4-Br---F4-PhOH, 2,3,5,6-Me4-pyrazine
(C6HBrF4O)(C8H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=4.4175(4)Å b=12.5878(13)Å c=13.4274(14)Å
α=80.827(4)° β=82.672(3)° γ=87.809(4)°
SD-1--22-2--5 4-Br---F4-PhCOOH, 1,2-bis(4-pyridyl)ethane
(C7HBrF4O2)(C12H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=4.8727(3)Å b=10.7621(7)Å c=16.5950(10)Å
α=87.808(2)° β=85.332(2)° γ=83.646(2)°
SD-1--20-9--7 4-I---F4-PhCH=NOH, Me4-pyrazine
(C7H2F4INO)(C8H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=4.1573(2)Å b=14.8817(8)Å c=26.2084(13)Å
α=90.00° β=91.3450(10)° γ=90.00°
CS---AS-9--11 4-I---F4-PhCHO oxime, 1,2-bis(4-pyridyl)ethane
(C7H2F4INO)(C12H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=6.2801(9)Å b=11.2226(15)Å c=26.846(4)Å
α=90.00° β=95.661(4)° γ=90.00°
SD-1--8-1--7 4-I---F4-PhCOOH, 2,3,5,6-Me4-pyrazine
(C7HF4IO2)(C8H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=17.5616(10)Å b=14.8078(9)Å c=6.1199(3)Å
α=90.00° β=90.00° γ=90.00°
SD---A-5--6 4-I---F4-PhCOOH, 4,4'-bipyridyl
(C7HIF4O2)(C10H8N2)
IUCrJ (2015) 2, Pt 5 498-510
a=12.1699(6)Å b=11.1933(6)Å c=12.2448(6)Å
α=90.00° β=104.562(2)° γ=90.00°
SD-1--27-6--5 1,2-bis(4-pyridyl)ethane, (4-Br-PhCOOH)2
(C12H12N2)(C7H5BrO2)2
IUCrJ (2015) 2, Pt 5 498-510
a=7.1108(4)Å b=7.4624(4)Å c=11.2299(6)Å
α=93.434(2)° β=94.022(2)° γ=103.373(2)°
CS---AL-6--12 4,4'-bipyridyl, (4-Br-PhCOOH)2
(C10H8N2)(C7H5BrO2)2
IUCrJ (2015) 2, Pt 5 498-510
a=11.0467(6)Å b=28.9658(18)Å c=10.7956(7)Å
α=90.00° β=110.603(2)° γ=90.00°
SD-1--20-10--8 (4-Br---F4-PhCH=NOH,)2 1,2-bis(4-pyridyl)ethylene
(C7H2BrF4NO)2(C12H10N2)
IUCrJ (2015) 2, Pt 5 498-510
a=5.8370(3)Å b=12.8464(5)Å c=18.1146(8)Å
α=103.537(2)° β=96.861(2)° γ=93.060(2)°
SD-1--20-12--6 (4-Br---F4-PhOH)2, 4,4-bipyridyl
(C6HBrF4O)2(C10H8N2)
IUCrJ (2015) 2, Pt 5 498-510
a=13.6342(15)Å b=5.8333(6)Å c=13.3118(14)Å
α=90.00° β=90.944(7)° γ=90.00°
SD-1--20-12--5, 4-Br---F4-PhOH, 1,2-bis(4-pyridyl)ethane
(C6HBrF4O)2(C12H12N2)
IUCrJ (2015) 2, Pt 5 498-510
a=25.9125(16)Å b=4.6925(3)Å c=20.0909(12)Å
α=90.00° β=103.464(3)° γ=90.00°
CS---AP-11--16 pyrazine 1-oxide, 4-I---F4-PhOH
(C4H4N2O)(C6HF4IO)
IUCrJ (2015) 2, Pt 5 498-510
a=11.701(2)Å b=4.6121(9)Å c=21.594(4)Å
α=90.00° β=103.591(6)° γ=90.00°
SD-1--8-1--10 4-I---F4-PhCOOH, pyrazine 1-oxide
(C7HF4IO2)(C4H4N2O)
IUCrJ (2015) 2, Pt 5 498-510
a=4.2485(3)Å b=11.6204(8)Å c=13.8288(10)Å
α=110.206(2)° β=95.9700(10)° γ=98.5310(10)°
CS---AP-11--2 4-I---F4-PhOH, isonicotinonitrile
(C6HF4IO)(C6H4N2)
IUCrJ (2015) 2, Pt 5 498-510
a=12.7258(15)Å b=4.9322(6)Å c=20.729(2)Å
α=90.00° β=106.074(3)° γ=90.00°
SD---A-5--1 4-I---F4-PhCOOH, isonicotinonitrile
(C7HIF4O2)(C6H4N2)
IUCrJ (2015) 2, Pt 5 498-510
a=7.4234(3)Å b=35.8851(18)Å c=10.0949(5)Å
α=90.00° β=101.028(2)° γ=90.00°
CS---AL-6--2 4-Br-PhCOOH, isonicotinonitrile
(C7H5BrO2)(C6H4N2)
IUCrJ (2015) 2, Pt 5 498-510
a=7.3630(12)Å b=7.4800(12)Å c=12.446(2)Å
α=80.617(8)° β=84.893(7)° γ=62.018(5)°
CS---AQ-12--2 4-Br---F4-PhOH, isonicotinonitrile
(C6HBrF4O)(C6H4N2)
IUCrJ (2015) 2, Pt 5 498-510
a=12.2763(19)Å b=5.0037(8)Å c=20.666(3)Å
α=90.00° β=106.425(4)° γ=90.00°
C8H8CdCl2N4O2
C8H8CdCl2N4O2
IUCrJ (2018) 5, 1
a=3.7833(3)Å b=7.6139(7)Å c=20.1473(18)Å
α=90° β=92.131(7)° γ=90°
C8H8CdI2N4O2
C8H8CdI2N4O2
IUCrJ (2018) 5, 1
a=4.1497(2)Å b=7.8783(4)Å c=21.0091(14)Å
α=90° β=92.551(4)° γ=90°
C8H8Br2CdN4O2
C8H8Br2CdN4O2
IUCrJ (2018) 5, 1
a=3.8840(3)Å b=23.164(2)Å c=7.0359(8)Å
α=90° β=93.712(9)° γ=90°
C8H8CdI2N4O2
C8H8CdI2N4O2
IUCrJ (2018) 5, 1
a=4.0953(3)Å b=7.8089(6)Å c=21.7078(13)Å
α=90° β=92.307(6)° γ=90°
C16H12Br2CdN4O2
C16H12Br2CdN4O2
IUCrJ (2018) 5, 1
a=18.2590(12)Å b=3.8670(2)Å c=24.2737(18)Å
α=90° β=95.491(6)° γ=90°
C16H12CdI2N4O2
C16H12CdI2N4O2
IUCrJ (2018) 5, 1
a=19.7099(5)Å b=6.8535(2)Å c=13.6310(4)Å
α=90° β=98.052(3)° γ=90°
CG-P2-L1-EtOAc N-(2-pyridylmethyl)-2,2-biimidazole
C12H11N5
Faraday Discuss. (2017)
a=21.5686(12)Å b=5.8077(3)Å c=18.0356(10)Å
α=90.00° β=110.1298(16)° γ=90.00°
CG-P2-A3-D7 [N-(4-pyridylmethyl)-2,2-biimidazole]2, 1,2-diiodotetrafluorobenzene
(C12H11N5)2(C6F4I2)
Faraday Discuss. (2017)
a=17.386(2)Å b=19.378(3)Å c=19.435(3)Å
α=92.996(5)° β=106.710(5)° γ=106.560(4)°
C18H21N5O4
C18H21N5O4
Faraday Discuss. (2017)
a=17.295(2)Å b=4.8014(7)Å c=21.977(3)Å
α=90° β=90.912(11)° γ=90°
C12H11N5
C12H11N5
Faraday Discuss. (2017)
a=5.493(2)Å b=10.339(4)Å c=10.611(4)Å
α=112.83(2)° β=99.24(3)° γ=94.16(3)°
C12H11N5,0.5(C6F4I2)
C12H11N5,0.5(C6F4I2)
Faraday Discuss. (2017)
a=5.0691(14)Å b=8.055(2)Å c=19.750(5)Å
α=93.952(13)° β=93.442(12)° γ=105.938(16)°
C12H11N5,C7H6O2
C12H11N5,C7H6O2
Faraday Discuss. (2017)
a=6.42690(10)Å b=9.9656(2)Å c=13.5194(3)Å
α=96.6910(10)° β=95.6860(10)° γ=100.6030(10)°
CG-P1-A1-HBD1 N-(2-pyridylmethyl)-2,2-biimidazole, HOOC-(CH2)2-COOH
(C12H11N5)(C4H6O4)
Faraday Discuss. (2017)
a=5.0716(9)Å b=11.314(2)Å c=14.051(3)Å
α=90.818(7)° β=99.190(6)° γ=99.925(6)°
C12H12N5,C8H13O4
C12H12N5,C8H13O4
Faraday Discuss. (2017)
a=5.1948(2)Å b=10.8967(3)Å c=18.2317(6)Å
α=105.5790(10)° β=95.6070(10)° γ=100.1040(10)°
CG-P2-A2-D10 N-(3-pyridylmethyl)-2,2-biimidazole, 1,3,5-F3-2,4,6-I3-benzene
(C12H11N5)(C6F3I3)
Faraday Discuss. (2017)
a=16.0707(15)Å b=9.0666(8)Å c=14.8610(14)Å
α=90.00° β=107.218(3)° γ=90.00°
C12H11N5,C7H6O2
C12H11N5,C7H6O2
Faraday Discuss. (2017)
a=7.028(2)Å b=9.024(3)Å c=13.602(4)Å
α=90.229(19)° β=91.564(17)° γ=93.223(16)°
C12H11N5
C12H11N5
Faraday Discuss. (2017)
a=7.490(3)Å b=9.841(4)Å c=15.253(5)Å
α=90° β=99.072(17)° γ=90°
C12H11N5,0.5(C6F4I2)
C12H11N5,0.5(C6F4I2)
Faraday Discuss. (2017)
a=5.4649(17)Å b=11.660(4)Å c=12.493(4)Å
α=84.163(17)° β=80.913(13)° γ=76.728(13)°
C12H11N5,0.5(C12H22O4)
C12H11N5,0.5(C12H22O4)
Faraday Discuss. (2017)
a=5.2936(3)Å b=7.9437(5)Å c=22.8847(13)Å
α=81.583(5)° β=85.500(6)° γ=70.615(5)°
CG-P2-A2-HBD2 [N-(3-pyridylmethyl)-2,2-biimidazole]2, HOOC-(CH2)8-COOH
(C12H11N5)2(C10H18O4)
Faraday Discuss. (2017)
a=5.7402(10)Å b=9.3514(16)Å c=14.973(3)Å
α=97.467(5)° β=91.771(6)° γ=97.861(5)°
CG-P2-A2-HBD2 [N-(3-pyridylmethyl)-2,2-biimidazole]2, HOOC-(CH2)4-COOH
(C12H11N5)2(C6H10O4)
Faraday Discuss. (2017)
a=8.0078(17)Å b=10.167(2)Å c=18.969(4)Å
α=79.276(6)° β=82.529(5)° γ=70.640(5)°
CG-P2-A3-HBD1 N-(4-pyridylmethyl)-2,2-biimidazole, HOOC-(CH2)2-COOH
(C12H11N5)(C4H6O4)
Faraday Discuss. (2017)
a=4.8081(7)Å b=11.0210(17)Å c=14.819(2)Å
α=97.881(6)° β=91.543(6)° γ=90.181(6)°
CG-P2-A3-D9 [N-(4-pyridylmethyl)-2,2-biimidazole]2, 1,4-diiodotetrafluorobenzene
(C12H11N5)2(C6F4I2)(C1H4O)
Faraday Discuss. (2017)
a=13.4945(9)Å b=14.8017(10)Å c=19.3714(13)Å
α=111.285(2)° β=92.518(2)° γ=112.668(2)°
3-(4-pyridyl)-pyrazole, 2,6-difluorobenzoic acid
(C8H7N3)(C7H4F2O2)
Molecular Pharmaceutics (2007) 4, 3 317
a=7.1555(8)Å b=17.958(2)Å c=10.9686(12)Å
α=90.00° β=101.301(2)° γ=90.00°
{1[(1-benzimidazolyl)methyl]-4[(1-pyrazolyl)methyl]benzene}2, succinic acid
(C18H16N4)2(C4H6O4)
Molecular Pharmaceutics (2007) 4, 3 317
a=5.6367(4)Å b=32.910(3)Å c=9.4476(7)Å
α=90.00° β=102.342(6)° γ=90.00°
MF-34-33 3-(4-pyridyl)pyrazole, (Me5-PhCOOH)2
(C8H7N3)(C12H16O2)2
Molecular Pharmaceutics (2007) 4, 3 317
a=8.8864(5)Å b=11.9875(7)Å c=13.7015(8)Å
α=99.3800(10)° β=93.1910(10)° γ=107.5560(10)°
1-[(1-benzimidazolyl)methyl]-3-[(1-pyrazolyl)methyl]benzene (3,5-diNO2PhCOOH)2
(C18H16N4)(C7H4N2O6)2
Molecular Pharmaceutics (2007) 4, 3 317
a=9.7657(6)Å b=11.7691(7)Å c=14.0803(9)Å
α=86.2270(10)° β=74.1630(10)° γ=86.2020(10)°
Hexyl bromo calixarene, dichloromethane
(C52H60Br4O8)(CH2Cl2)
Organic letters (2006) 8, 12 2607-2610
a=10.4432(15)Å b=15.049(2)Å c=16.320(2)Å
α=90.00° β=97.977(3)° γ=90.00°
NS 14 pentyl calixarene (+ octanedioic acid)
(C72H76N4O8)2(CH4O)7
Organic letters (2006) 8, 12 2607-2610
a=23.3560(16)Å b=22.1519(16)Å c=25.5165(16)Å
α=90.00° β=94.302(4)° γ=90.00°
C24H18CuF12N4O6
C24H18CuF12N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=8.5710(4)Å b=8.6068(5)Å c=10.9486(6)Å
α=96.577(5)° β=106.692(6)° γ=102.284(5)°
C24H24CuF6N4O6
C24H24CuF6N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=8.9094(2)Å b=8.9094(2)Å c=33.9781(12)Å
α=90° β=90° γ=90°
C22H14CuF12N4O6
C22H14CuF12N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=6.9635(12)Å b=10.0912(14)Å c=10.3229(16)Å
α=69.049(14)° β=80.726(14)° γ=83.957(15)°
C24H24CuF6N4O6
C24H24CuF6N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=8.5478(4)Å b=9.2084(4)Å c=10.0669(5)Å
α=114.584(4)° β=99.527(4)° γ=98.514(4)°
C34H22CuF12N4O6
C34H22CuF12N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=9.0451(4)Å b=10.1886(5)Å c=10.3628(4)Å
α=105.030(4)° β=97.391(4)° γ=93.535(4)°
C34H28CuF6N4O6
C34H28CuF6N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=10.3647(2)Å b=9.6311(2)Å c=17.9637(5)Å
α=90° β=100.920(2)° γ=90°
C34H22CuF12N4O6
C34H22CuF12N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=11.3294(5)Å b=22.7479(6)Å c=7.3599(3)Å
α=90° β=103.836(4)° γ=90°
C24H18CuF12N4O6
C24H18CuF12N4O6
Dalton transactions (Cambridge, England : 2003) (2019)
a=6.7979(6)Å b=10.8757(6)Å c=11.5285(8)Å
α=117.344(6)° β=90.254(7)° γ=98.312(6)°
C16H14CuF6N2O5
C16H14CuF6N2O5
Dalton transactions (Cambridge, England : 2003) (2019)
a=6.7411(3)Å b=15.9660(8)Å c=18.5837(6)Å
α=90° β=94.453(3)° γ=90°
C33H16I4,C24H20P,Br
C33H16I4,C24H20P,Br
Chemical communications (Cambridge, England) (2018) 54, 6 607-610
a=17.4076(9)Å b=17.4445(11)Å c=34.0495(19)Å
α=90° β=90.184(4)° γ=90°
C33H16I4,C24H20P,I
C33H16I4,C24H20P,I
Chemical communications (Cambridge, England) (2018) 54, 6 607-610
a=17.4190(11)Å b=17.3989(8)Å c=34.9081(17)Å
α=90° β=90.638(6)° γ=90°
C33H16I4,C24H20P,Cl
C33H16I4,C24H20P,Cl
Chemical communications (Cambridge, England) (2018) 54, 6 607-610
a=17.3730(6)Å b=17.4497(7)Å c=33.5122(11)Å
α=90° β=90.168(4)° γ=90°
C6H5NO3,CH4N2O
C6H5NO3,CH4N2O
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=7.2016(19)Å b=26.812(6)Å c=9.497(2)Å
α=90° β=104.392(13)° γ=90°
BS-II-U-5 (urea)2, citric acid
C6H8O7,2(CH4N2O)
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=6.5395(5)Å b=6.7758(5)Å c=15.2596(11)Å
α=81.525(2)° β=85.861(2)° γ=74.230(2)°
BS-II-U-79 urea, 2,3,5,6-Me4-pyrazine-1,4-dioxide
C8H12N2O2,CH4N2O
Chemical communications (Cambridge, England) (2018) 54, 37 4657-4660
a=11.6812(10)Å b=13.2376(12)Å c=6.9737(6)Å
α=90.00° β=100.298(4)° γ=90.00°
C10H10I2O2,H2O
C10H10I2O2,H2O
New Journal of Chemistry (2018) 42, 13 10539
a=8.5167(5)Å b=8.5167(5)Å c=8.8404(9)Å
α=90° β=90° γ=90°
C12H12N2,C10H12O2
C12H12N2,C10H12O2
New Journal of Chemistry (2018) 42, 13 10539
a=11.5202(15)Å b=7.7849(10)Å c=11.8577(16)Å
α=90° β=114.559(2)° γ=90°
C10H10I2O2
C10H10I2O2
New Journal of Chemistry (2018) 42, 13 10539
a=11.1961(17)Å b=11.5073(18)Å c=9.2386(15)Å
α=90° β=100.613(4)° γ=90°
C10H10I2O2,C12H12N2
C10H10I2O2,C12H12N2
New Journal of Chemistry (2018) 42, 13 10539
a=7.8440(14)Å b=11.568(2)Å c=12.755(2)Å
α=92.124(6)° β=97.154(6)° γ=109.722(6)°
C10H10I2O2,C10H8N2
C10H10I2O2,C10H8N2
New Journal of Chemistry (2018) 42, 13 10539
a=9.5108(4)Å b=10.5838(6)Å c=22.0298(8)Å
α=90° β=100.451(4)° γ=90°
C10H10I2O2,C10H8N2
C10H10I2O2,C10H8N2
New Journal of Chemistry (2018) 42, 13 10539
a=7.7674(8)Å b=10.0010(10)Å c=26.238(3)Å
α=81.2340(10)° β=89.2680(10)° γ=85.8440(10)°
C10H10I2O2,C12H10N2
C10H10I2O2,C12H10N2
New Journal of Chemistry (2018) 42, 13 10539
a=7.8373(7)Å b=11.6273(11)Å c=12.6853(12)Å
α=93.5792(12)° β=96.5739(11)° γ=107.2327(11)°
C10H12O2,C10H8N2
C10H12O2,C10H8N2
New Journal of Chemistry (2018) 42, 13 10539
a=5.9239(5)Å b=12.3895(9)Å c=13.2181(8)Å
α=110.998(6)° β=96.684(6)° γ=99.359(6)°
1,4-diacetylbenzenedioxime
C10H12N2O2
New J. Chem. (2003) 27, 7 1084-1094
a=8.1553(14)Å b=14.208(3)Å c=8.5134(14)Å
α=90.00° β=108.525(4)° γ=90.00°
1,3-diacetylbenzemedioxime
C10H12N2O2
New J. Chem. (2003) 27, 7 1084-1094
a=3.897(2)Å b=14.757(9)Å c=16.305(9)Å
α=90.00° β=91.668(14)° γ=90.00°
Fumaramidioxime
C4H8N4O2
New J. Chem. (2003) 27, 7 1084-1094
a=16.6296(17)Å b=3.6679(3)Å c=10.0529(10)Å
α=90.00° β=90.00° γ=90.00°
E,E-1,3-benzenediamidioxime
C8H10N4O2
New J. Chem. (2003) 27, 7 1084-1094
a=13.1956(15)Å b=12.1099(17)Å c=11.8156(17)Å
α=90.00° β=101.412(8)° γ=90.00°
E,E-terephathalaldoxime
C8H8N2O2
New J. Chem. (2003) 27, 7 1084-1094
a=13.6142(8)Å b=4.5032(3)Å c=13.1697(8)Å
α=90.00° β=107.263(4)° γ=90.00°
E,E-isophthalaldoxime
C8H8N2O2
New J. Chem. (2003) 27, 7 1084-1094
a=10.1860(4)Å b=11.0510(3)Å c=7.6536(3)Å
α=90.00° β=119.445(2)° γ=90.00°
1,4-benzenediamidioxime
C8H10N4O2
New J. Chem. (2003) 27, 7 1084-1094
a=8.401(6)Å b=4.985(5)Å c=10.714(10)Å
α=90.00° β=107.41(7)° γ=90.00°
Succinamidioxime
C4H10N4O2
New J. Chem. (2003) 27, 7 1084-1094
a=4.8552(5)Å b=5.1714(2)Å c=13.2126(8)Å
α=90.00° β=100.205(6)° γ=90.00°
TW-2B-19 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)2-COOH
(C18H16N6)(C4H6O4)
New J. Chem. (2015) 39, 2 822
a=4.8468(8)Å b=9.2594(16)Å c=12.245(2)Å
α=69.536(7)° β=89.567(7)° γ=85.993(7)°
TW-2B-20 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)4-COOH
(C18H16N6)(C6H10O4)
New J. Chem. (2015) 39, 2 822
a=5.5146(11)Å b=6.8100(14)Å c=15.254(3)Å
α=79.288(6)° β=85.259(6)° γ=75.952(5)°
TW-2B-21 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)6-COOH
(C18H16N6)(C8H14O4)
New J. Chem. (2015) 39, 2 822
a=5.6196(11)Å b=6.7825(13)Å c=16.078(3)Å
α=87.236(4)° β=82.669(4)° γ=75.451(4)°
TW-2B-22 1,1'-di[(3-pyridyl)methyl]-2,2'-biimidazole, HOOCH-(CH2)8-COOH
(C18H16N6)(C10H18O4)
New J. Chem. (2015) 39, 2 822
a=5.6320(7)Å b=6.8450(8)Å c=17.748(2)Å
α=93.630(7)° β=98.988(7)° γ=104.670(7)°
TW-2B-23 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)10-COOH
(C18H16N6)(C12H22O4)
New J. Chem. (2015) 39, 2 822
a=5.6047(8)Å b=6.8589(10)Å c=18.879(3)Å
α=97.644(5)° β=91.164(5)° γ=104.659(5)°
TW-2B-24-C 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)-COOH
(C18H16N6)(C3H4O4)
New J. Chem. (2015) 39, 2 822
a=14.797(3)Å b=4.5097(7)Å c=29.886(5)Å
α=90.00° β=104.056(8)° γ=90.00°
TW-2B-25-SE 1,1'-di[(4-pyridyl)methyl]-2,2'-biimidazole, (HOOC-(CH2)3-COOH)2
(C18H16N6)(C5H8O4)2
New J. Chem. (2015) 39, 2 822
a=7.6142(11)Å b=8.6608(13)Å c=11.0348(16)Å
α=102.357(5)° β=105.996(5)° γ=93.866(5)°
TW-2B-2 1,1'-di[(2-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)4-COOH
(C18H16N6)(C6H10O4)
New J. Chem. (2015) 39, 2 822
a=5.0121(5)Å b=7.8964(8)Å c=15.1589(16)Å
α=78.403(4)° β=88.333(4)° γ=72.636(3)°
TW-2B-3 1,1'-di[(2-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)6-COOH
(C18H16N6)(C8H14O4)
New J. Chem. (2015) 39, 2 822
a=5.1024(10)Å b=8.0128(15)Å c=16.497(3)Å
α=99.940(9)° β=93.967(10)° γ=108.231(8)°
TW-2B-4 1,1'-di[(2-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)8-COOH
(C18H16N6)(C10H18O4)
New J. Chem. (2015) 39, 2 822
a=5.2731(8)Å b=7.8464(11)Å c=17.163(3)Å
α=81.964(6)° β=88.938(6)° γ=72.499(6)°
TW-2B-5 1,1'-di[(2-pyridyl)methyl]-2,2'-biimidazole, HOOC-(CH2)10-COOH
(C18H16N6)(C12H22O4)
New J. Chem. (2015) 39, 2 822
a=5.2955(8)Å b=7.8185(13)Å c=18.424(3)Å
α=85.042(10)° β=83.543(10)° γ=71.912(10)°
TW-2B-33 1,1'-di[(phenyl)methyl]-2,2'-biimidazole, HOOC-CH2-COOH
(C20H18N4)(C3H4O4)
New J. Chem. (2015) 39, 2 822
a=11.4449(17)Å b=8.9002(15)Å c=21.338(3)Å
α=90.00° β=94.855(10)° γ=90.00°
4-((1-pyrazolyl)methyl)benzamide
C11H11N3O
New Journal of Chemistry (2007) 31, 12 2044
a=21.660(4)Å b=4.7544(9)Å c=9.9321(19)Å
α=90.00° β=93.912(3)° γ=90.00°
4-((3,5-dimethylpyrazol-1-yl)methyl)benzamide
(C13H15N3O)
New Journal of Chemistry (2007) 31, 12 2044
a=8.4005(7)Å b=8.0671(7)Å c=18.0477(18)Å
α=90.00° β=102.621(6)° γ=90.00°
BS-3-93-3G 3-((4-bromo-3,5-dimethylpyrazol-1- yl)methyl)benzamide, succinic acid
C13H14BrN3O
New Journal of Chemistry (2007) 31, 12 2044
a=12.437(3)Å b=8.8195(17)Å c=12.468(2)Å
α=90.00° β=114.488(6)° γ=90.00°
BS-3-92-4 3-((3,5-dimethylpyrazol-1-yl)methyl)benzamide
C13H15N3O
New Journal of Chemistry (2007) 31, 12 2044
a=8.0162(4)Å b=8.0603(4)Å c=10.4542(5)Å
α=97.253(2)° β=106.060(2)° γ=109.335(2)°